Literature DB >> 23831163

Impact of a multidisciplinary management strategy on the outcome of patients with native valve infective endocarditis.

Fabio Chirillo1, Piergiorgio Scotton, Francesco Rocco, Roberto Rigoli, Francesca Borsatto, Alessandra Pedrocco, Alessandro De Leo, Giuseppe Minniti, Elvio Polesel, Zoran Olivari.   

Abstract

Strategies to improve management of patients with native valve endocarditis (NVE) are needed because of persistently high morbidity and mortality. We sought to assess the impact of an operative protocol of multidisciplinary approach on the outcome of patients with NVE. A formal policy for the care of infective endocarditis was introduced at our hospital in 2003 in which patients were referred to and managed by a preexisting team involving a cardiologist, a specialist in infectious diseases, and a cardiac surgeon. The initial multidisciplinary evaluation was performed within 12 hours of admission. Whenever conditions associated with impending hemodynamic impairment, high-risk for systemic embolization, or unsuccessful medical therapy were found, patients were operated on within 48 hours. Stable patients were evaluated weekly by the multidisciplinary team, and on-treatment surgery was performed whenever the above high-risk conditions had developed. Comparing the period 2003 through 2009 with 1996 through 2002 (when a multidisciplinary policy was not followed), patients were more numerous (190 vs 102), older (mean age 59.1 vs 54.2, p = 0.01), and had more co-morbidities (mean Charlson index 3.01 vs 2.31, p = 0.02). The pattern of infection did not change in terms of valve infected or paravalvular complications. In the second period, fewer patients had culture-negative NVE (8% vs 21%, p = 0.01) and worsened renal function (37% vs 58%, p = 0.001). A significant reduction in overall in-hospital mortality (28% to 13%, p = 0.02), mortality for surgery during the active phase (47% to 13%, p ≤0.001), and 3-year mortality (34% vs 16%, p = 0.0007) was observed. In conclusion, formalized, collaborative management led to significant improvement in NVE-related mortality, notwithstanding the less favorable patients' baseline characteristics.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23831163     DOI: 10.1016/j.amjcard.2013.05.060

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  28 in total

1.  Long-term antibiotic therapy in patients with surgery-indicated not undergoing surgery infective endocarditis.

Authors:  Nuria Vallejo Camazon; Lourdes Mateu; Germán Cediel; Laura Escolà-Vergé; Nuria Fernández-Hidalgo; Mercedes Gurgui Ferrer; Maria Teresa Perez Rodriguez; Guillermo Cuervo; Raquel Nuñez Aragón; Cinta Llibre; Nieves Sopena; Maria Dolores Quesada; Elisabeth Berastegui; Albert Teis; Jorge Lopez Ayerbe; Gladys Juncà; Francisco Gual; Elena Ferrer Sistach; Ainhoa Vivero; Esteban Reynaga; Maria Hernández Pérez; Christian Muñoz Guijosa; Lluisa Pedro-Botet; Antoni Bayés-Genís
Journal:  Cardiol J       Date:  2021-05-25       Impact factor: 2.737

Review 2.  The Changing Epidemiology of Infective Endocarditis in the Twenty-First Century.

Authors:  J Ambrosioni; M Hernandez-Meneses; A Téllez; J Pericàs; C Falces; J M Tolosana; B Vidal; M Almela; E Quintana; J Llopis; A Moreno; José M Miro
Journal:  Curr Infect Dis Rep       Date:  2017-05       Impact factor: 3.725

3.  The round table approach in infective endocarditis & cardiovascular implantable electronic devices infections: make your e-Team come true.

Authors:  Paola A Erba; Gilbert Habib; Andor W J M Glaudemans; Jose M Miro; Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-07       Impact factor: 9.236

Review 4.  [Infective endocarditis : New ESC guidelines 2015].

Authors:  B Plicht; A Lind; R Erbel
Journal:  Internist (Berl)       Date:  2016-07       Impact factor: 0.743

5.  Factors associated with unfavorable outcome in a multicenter audit of 100 infective endocarditis.

Authors:  David Chirio; Marion Le Marechal; Pamela Moceri; Arnaud de la Chapelle; Sylvie Chaillou-Optiz; Anaïs Mothes; Cédric Foucault; Laurence Maulin; Chirine Parsaï; Pierre-Marie Roger; Elisa Demonchy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-10-15       Impact factor: 3.267

6.  Infectious disease services: a survey from four university hospitals in Germany.

Authors:  Siegbert Rieg; Florian Hitzenbichler; Stefan Hagel; Isabelle Suarez; Florian Kron; Bernd Salzberger; Mathias Pletz; Winfried V Kern; Gerd Fätkenheuer; Norma Jung
Journal:  Infection       Date:  2018-08-17       Impact factor: 3.553

Review 7.  Infective endocarditis: therapeutic options and indications for surgery.

Authors:  Aneil Malhotra; Jenny Rayner; Timothy M Williams; Bernard Prendergast
Journal:  Curr Cardiol Rep       Date:  2014-04       Impact factor: 2.931

8.  The clinical value of the endocarditis team: insights from before and after guidelines implementation strategy.

Authors:  Boaz Elad; Leor Perl; Ashraf Hamdan; Dafna Yahav; Alaa Atamna; Hila Shaked; Victor Rubchevsky; Ram Sharony; Hanna Bernstine; Yaron Shapira; Mordehay Vaturi; Hadas Ofek; Alexander Sagie; Ran Kornowski; Katia Orvin
Journal:  Infection       Date:  2021-06-05       Impact factor: 3.553

9.  Heart transplantation as salvage therapy for progressive prosthetic valve endocarditis due to methicillin-resistant Staphylococcus epidermidis (MRSE).

Authors:  J P Borde; G Sitaru; W H Kopp; A Ruhparwar; P Ehlermann; F Lasitschka; A Dalpke; A Heininger
Journal:  J Cardiothorac Surg       Date:  2016-07-11       Impact factor: 1.637

10.  Diagnostic tools in surgically treated patients with infective valve endocarditis.

Authors:  Guenther Kroegh; Khalil Jawad; Piroze Davierwala; Michael Borger; Martin Misfeld
Journal:  Ann Cardiothorac Surg       Date:  2019-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.